Inventor · disambiguated record
Robert Pitti
Also filed as: PITTI ROBERT · PITTI ROBERT M · PITTI ROBERT MAURICE
8 granted patents·24 pending applications·172 citations·filing 1997–2015
87Inventor score
Top patents by PatentIndex Score
32 records- 0192US6764679B2Antibodies to DcR3 Polypeptide, a TNFR HomologGENENTECH INC·Filed 2001·Granted Jul 20, 2004·38 cites·33 claims
- 0282US6005117AImino compounds, process for their preparation and their use as victronectin antagonistsHOECHST AG·Filed 1997·Granted Dec 21, 1999·59 cites·17 claims
- 0378US7799899B2Compositions and methods relating to STOP-1GENENTECH INC·Filed 2004·Granted Sep 21, 2010·14 cites·19 claims
- 0477US6740739B1Substitutional variants of APO-2 ligandGENENTECH INC·Filed 1999·Granted May 25, 2004·37 cites·4 claims
- 0577US6399620B1Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonistsHOECHST AG·Filed 2000·Granted Jun 4, 2002·8 cites·14 claims
- 0674US2010080793A1DcR3 polypeptide, A TNFR homologGENENTECH INC·Filed 2008·Application pending·0 cites
- 0764US2010010195A1Novel tumor necrosis factor receptor homolog and nucleic acids encoding the sameGENENTECH INC·Filed 2009·Application pending·0 cites
- 0864US2007041983A1Method for treating tumors using anti-osteopontin antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 0963US2004175791A1DcR3 polypeptide, a TNFR homologGENENTECH INC·Filed 2003·Application pending·0 cites
- 1062US2007072263A1DNA19355 polypeptide, a tumor necrosis factor homologGENENTECH INC·Filed 2005·Application pending·0 cites
- 1162US2004234498A1DNA19355 polypeptide, a tumor necrosis factor homologGENENTECH INC·Filed 2003·Application pending·0 cites
- 1262US2004014176A1DcR3 polypeptide, a TNFR homologGENENTECH INC·Filed 2003·Application pending·0 cites
- 1362US2009191184A1DcR3 polypeptide, A TNFR homologGENENTECH INC·Filed 2008·Application pending·0 cites
- 1461US2003211096A1Compositions and methods for the treatment of tumorGENENTECH INC·Filed 2002·Application pending·0 cites
- 1560US2008021055A1Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonistsAVENTIS PHARMA SA·Filed 2007·Application pending·0 cites
- 1660US2003170228A1Compositions and methods for the treatment of tumorGENENTECH INC·Filed 2002·Application pending·0 cites
- 1760US2005226868A1Method for treating tumors using anti-osteopontin antibodiesASHKENAZI AVI J·Filed 2004·Application pending·0 cites
- 1860US2003175900A1Compositions and methods for the treatment of tumorGENENTECH INC·Filed 2002·Application pending·0 cites
- 1959US6221907B1Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing sameHOECHST MARION ROUSSEL INC·Filed 1997·Granted Apr 24, 2001·16 cites·12 claims
- 2056US2006216270A1DNA 19355 polypeptide, a tumor necrosis factor homologGENENTECH INC·Filed 2006·Application pending·0 cites
- 2156US2005069983A1Novel tumor necrosis factor receptor homolog and nucleic acids encoding the sameGENENTECH INC·Filed 2004·Application pending·0 cites
- 2255US2006141573A1Novel tumor necrosis factor receptor homolog and nucleic acids encoding the sameGENENTECH INC·Filed 2005·Application pending·0 cites
- 2352US2008213837A1Apo-3 ligand polypeptideGENENTECH INC·Filed 2007·Application pending·0 cites
- 2451US7348333B2Cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonistsAVENTIS PHARMA SA·Filed 2002·Granted Mar 25, 2008·0 cites·5 claims
- 2551US2004231011A1DcR3 polypeptide, a TNFR homologGENENTECH INC·Filed 2004·Application pending·0 cites
- 2651US2008171037A1Apo-3 ligand polypeptideGENENTECH INC·Filed 2007·Application pending·0 cites
- 2750US2002150993A1Novel tumor necrosis factor receptor homolog and nucleic acids encoding the sameGENENTECH INC·Filed 2002·Application pending·0 cites
- 2850US2002146389A1DNA19355 polypeptide, a tumor necrosis factor homologGENENTECH INC·Filed 2002·Application pending·0 cites
- 2940US2017209444A1Methods of treating cancer and preventing cancer drug resistanceGENENTECH INC·Filed 2015·Application pending·0 cites
- 3039US2011112279A1Compositions and Methods Relating to STOP-1GENENTECH INC·Filed 2010·Application pending·0 cites
- 3137US2006073146A1Uses of agonists and antagonists to modulate activity of TNF-related moleculesGENENTECH INC·Filed 2005·Application pending·0 cites
- 3236US6459001B1Tricyclic compounds, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2001·Granted Oct 1, 2002·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Robert Pitti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →